Bojan Trkulja, managing director of INOVIA, Serbia’s innovative drug manufacturers association, underlines the importance of cooperation not only between his members but also between all the key stakeholders of the Serbian healthcare and life science industry, concluding that the time for investment in Serbia is now and that the country has undiscovered opportunities waiting to be explored.
Where does INOVIA stand today and what are the priorities for 2017/18?
"Serbia has such agreements and tax laws with the EU allowing us to import and export goods without paying customs."
